Astellas Pharma Inc: Astellas Confirms Unfavorable District Court Decision Concerning Its Motion for a Preliminary Injunction Against Generic Versions of Myrbetriq
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.